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Abstract
In Europe, theoretical approaches to physical therapy and rehabilitation in multiple sclerosis often appear signifi-
cantly different. While there is general agreement that rehabilitation plays an important role in maintaining and
improving function in persons with multiple sclerosis, no consensus exists on what may be the most effective
approach to achieve the best possible functionality within an individual’s limitations.
The objective of this paper is to initiate an analysis of currently applied physical interventions for people with mul-
tiple sclerosis throughout Europe during inpatient or outpatient rehabilitation programs. A study of the content of
rehabilitation may show presently performed treatment methods revealing the basic considerations that nowadays
guide clinicians implicitly or explicitly in the treatment of persons with multiple sclerosis. Following this first step,
comparative studies can be set up.
Introduction
Neurological abnormalities due to multiple sclerosis
(MS) manifest themselves with a wide range of symp-
toms like fatigue, numbness, paraesthesias, muscular
weakness and spasticity, double vision, optic neuritis,
ataxia, bladder control problems, dysphagia, dysarthria
and cognitive dysfunction. These impairments can lead
to relevant problems in carrying out activities of daily
living, and participation, too. Therefore, rehabilitation is
focused on functional disabilities evolving from the
reported symptoms such as balance disorders, gait
abnormalities, etc. Symptoms of MS are of different
severity and thus cause different problems in every stage
of the disease [1-3].
There is no curative treatment available for MS yet.
Despite the fact that drug-induced immunosuppression
and immunomodulation have been shown to decelerate
the inflammatory-related progression of MS [4-7], there
are numerous symptoms (such as fatigue, pain, spasti-
city, bladder dysfunction) and considerable disabilities
(such as reduction of mobility, communication, and
cognitive function) that develop during the course of
the disease and require specific symptomatic treatments
[8]. Symptomatic treatment [2] does not include only
drugs but additionally a large body of functional inter-
ventions, especially physical treatment methods, occupa-
tional, speech and swallowing therapy, as well as
neuropsychological training, which are all important
parts of comprehensive rehabilitation programs. Symp-
tomatic drug treatment and rehabilitation are both
recommended to stabilise or improve the functional
status of person with multiple sclerosis (PwMS).
Discussion
Empirical evidence for a basis of rehabilitation
The processes that lead to functional recovery after
rehabilitation have been intensively debated within the
last years. Rehabilitation in general “has moved from
professional artistry to an evidence-based scientific
approach over the last 15-20 years”. This very clear and
refined statement by D. Richardson [9] is true for MS
rehabilitation, too. In the past, MS rehabilitation was
performed only rarely and non-systematically but is now
steadily maturing and being attributed more importance
due to the following observations: * Correspondence: kamila.rasova@centrum.cz
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on fundamental aspects underlying rehabilitation
has emerged including:
￿ growing knowledge about neuroplasticity and
the ability of the central nervous system to trig-
ger and/or promote reorganization of damaged
structures and function,
￿ better understanding of the biochemical factors
that promote learning and neural remodelling
(neurotrophic factors, neurotransmitters, etc.) in
a close relationship with the activation or reacti-
vation of neural cell precursors, responsible for
reparative processes,
￿ advances in the understanding of neuropsycho-
logical factors, such as the systems of memory,
executive function and attention (all of which are
cognitive functions often altered in MS patients);
increasing knowledge of motor control and
motor learning [10,11].
⇨ Rehabilitation in general as well as specific phy-
sical interventions have been shown to be effective.
In the last decade the number, as well as the qual-
ity of published scientific studies and systematic
reviews in MS rehabilitation have clearly increased
[3,12]. Studies have revealed short- and long-term
beneficial effects of comprehensive rehabilitation
programs (multimodal rehabilitation) [12-15] also
studies of physical interventions, including exercise
therapy, have demonstrated their effectiveness
[16-20].
⇨ Contextual changes in the rehabilitation field
revealing
￿ an understanding of the importance of properly
classifying and recognizing the different health
problems that a patient is confronted with, using
the International Classification of Functioning,
Disability and Health (ICF), a globally-agreed-
upon framework of the World Health Organiza-
tion. It was recently recommended that clinical
practice in MS, including rehabilitation, should
be based on this classification system which
relates the typical spectrum of problems in func-
tioning of PwMS with their personal attitudes
and the environmental context in which they live
[21]. This approach is essential for assessment
and selection of the best strategies for rehabilita-
tion [22,23],
￿ the awareness of the necessity of implementing
evidence-based knowledge and practice (patient’s
values, therapist’s experience, and scientific evi-
dence) into rehabilitation,
￿ an increasing interest in Health-related Quality
of Life as an essential outcome measure for treat-
ment [24,25].
⇨ Increased political attention towards high-qual-
ity rehabilitation for MS and equal chances of
access. Rehabilitation in chronically disabled people
like PwMS has gained growing attention. This is one
of the reasons why the European MS Platform
(EMSP) developed and published the “Code of Good
Practice” claiming that all PwMS throughout Europe
should have “equal rights and access to treatment,
therapies and services in the management of Multi-
ple Sclerosis” [26]. This document has been
endorsed by the European Parliament, and as such,
rehabilitation in MS has been more widely accepted.
Nowadays, it is important to work on the political
and legislative implementation of the Code of Good
Practice of Rehabilitation (early, long term, aimed,
comprehensive, and attainable for everybody) across
Europe, and ensure access to care.
Drawbacks in current practice and research
First, MS is an individually variable and unpredictable
disease needing evaluation at different assessment levels
(impairment, disability, handicap, quality of life), includ-
ing patient-reported outcome measures. Unfortunately,
both researchers and therapists currently use too many
different measures or do not address all levels of
patient/therapist perspectives, thus making it difficult to
directly compare the effectiveness of interventions
(about 2600 articles have been found in PubMed about
outcome measures in MS). Interestingly, regional differ-
ences in using specific outcome measures in MS across
Europe were reported in a study of Haigh et al. [27].
The Authors found some variation in the preference for
specific measures across Europe. The differing choice
between competing instruments, such as the Functional
Independence Measure versus the Barthel Index, was
likely related to the specific contexts in different regions
rather than discussion on the need of the domains to be
measured. A surprising finding was the low level of use
of the so-called ‘generic measures’ in routine clinical
practice. At the XIII. SIG Mobility of RIMS (Rehabilita-
tion in Multiple Sclerosis, the European network of MS
centres) meeting “Content of physical rehabilitation in
multiple sclerosis” 2010, different approaches to evalua-
tion were presented, for example an application of the
ICF in documenting the term limitations of the MS dis-
ease, goal attainment scaling (GAS) - a method for rat-
ing goal achievement, and Patient Reported Outcomes
Measurement Information Systems (PROMIS) - recently
used modern psychometric Theory. The use of each
approach probably depends on social and health policy
system in each country [28]. The role of policy systems
in disparities within Europe is mentioned in a very
recent study [29] that compared treatment and care of
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culture, and economical and politic systems. Prodiner
et al. 2010 [30] confirmed that policy factors influence
participation in work or social life and recommended
the development of participation outcome measure-
ments. No study until now has evaluated the impact of
socio-political environment on the choice of outcome
measures within Europe, an issue that should be studied
in the future. In line with Kwakkel et al. [31], we advo-
cate to reach for a world-wide consensus on the use of
outcome measures in MS rather than development of
new ones. In this regard, the ICF ‘core set’ for MS
should be considered [22]. We also encourage current
collaborative activities within RIMS and CMSC, the
Consortium of Multiple Sclerosis Centers, to reach con-
sensus on gait and fatigue outcome measures for MS
[32]. A common set of outcome measures will at a later
stage facilitate comprehensive meta-analyses which
could better reflect the true efficacy of rehabilitation in
MS than individual studies with small sample sizes.
Besides, it is likely that a modular evaluation approach
is needed given the broad variety in severity of symp-
toms that may occur between and within patients [33].
Second, even though an increasing number of studies
have been published in the field of physical rehabilita-
tion (about 1000 articles were found in PubMed about
physical rehabilitation in MS from 1960 s until now),
there is still restricted conclusive scientific evidence for
the efficacy of treatment interventions in MS. This is
related not only to the use of different outcome mea-
sures or limited sample sizes, but also to the variety in
patient characteristics (severity of symptoms, type of
MS, age, subjective factors), treatment goals, treatment
setting (in-patient versus out-patient care, multi-disci-
plinary versus isolated intervention), duration and inten-
sity (“dosage”) of treatment as well as time points of
measurements (pre, post as well as follow-up)
[3,12-15,18,19,34-38]. As a consequence, even with
available studies regarding certain interventions, it
remains sometimes unclear which interventions are
effective at what stage of MS or at which level of dis-
ability, which leads to limited transfer of evidence into
daily practice. We acknowledge that some of these fac-
tors are likely to be influenced by the local organization
of rehabilitation but emphasize a better standardization
when doing research.
Third, it is widely agreed that physical rehabilitation
includes a variety of techniques and conceptual treat-
m e n tm e t h o d st h a ta r en o ty e ts t u d i e db yr i g o r o u s
scientific methods but nevertheless may be of value. For
example the effectiveness of Vojta reflex locomotion,
Proprioceptive neuromuscular facilitation or Perfetti
concept and other generally known and accredited
methods, has not been scientifically confirmed in MS
(no publication was found in PubMed about the above
mentioned methods in MS). Education, culture, history
and the way of philosophical thinking (how the patient
is being perceived); focus on symptomatic or facilitation
or task-oriented intervention [39]) have led to different
kinds of therapeutic approaches across Europe which
will be briefly discussed below. We are convinced, that a
main drawback in current clinical practice and research
is that the precise content of interventions is often
poorly documented (what were therapist and patient
really doing during intervention?) while, on the other
hand, different terminology may be used to address
similar approaches. An inventory of current content of
rehabilitation defined for different symptoms, symptom
severity, functioning problems and treatment goals
would facilitate exchange of therapeutic knowledge and
a set-up of comparative studies in MS.
Fourth, different Health Systems and Policies (Funding
Health Care, Human Resources for Health, Health Ser-
vices Management, Health Economics, Health Technol-
ogy Assessment, decentralization versus centralisation in
Health Care, private versus public Medical Insurance,
Social Health Insurance systems, Assuring quality of
Health Care, Caring for People with Chronic Condi-
tions, Primary Care, Disease Prevention, etc.) have an
impact on rehabilitation and physiotherapy approaches
and methods. Also the educational systems and highest
levels in physiotherapy (professional bachelors versus
academic masters) are still different in European coun-
tries including the access to postgraduate education
[40,41]. This topic has not been mapped in MS yet.
Fifth, the gap between what is known about effective
health services and what is done in real-world practice
exists. Deficiencies in the adoption of new strategies and
findings in clinical practice were found [42]. It is impor-
tant to understand how information from research stu-
dies and non-evidence-based opinions (opinion from
clinical expert leaders, universities, consumers, direct
service providers etc.) is transferred to the clinical field
and to what extent it may be the barrier that hampers
the transfer of new knowledge [43,44]. Cabana et al.,
1999 [43] categorized types of the barriers: lack of
awareness (the difficulty to be aware of every applicable
approach and critically apply it to practice), lack of
familiarity with new evidence, lack of agreement with
new approaches, lack of self-efficacy (the belief that one
can actually perform a change in clinical practice), lack
of outcome expectancy on new methods, inertia of pre-
vious practice of clinicians that may not have the moti-
vation to change, patient-related barriers (the inability
to reconcile patient preferences with recommendations
and environmental-related barriers that address the
acquisition of new resources or facilities). Dissemination
for outcome measures and description of new
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standard possibilities of information dissemination like
using print information materials (leaflets, posters), mass
media including internet, shows and exhibitions, scienti-
fic publications or papers, there are more effective tech-
niques like self-directed curricula and small group
interactions that help learners assess the discrepancy
between what they ought to know or do and what they
know or do, and provide opportunities to try out an
innovation before putting it into practice [43]. However
these techniques are time and cost consuming, too
dependent upon local health organizations and on trans-
lation techniques that can be problematic (e.g. transla-
tion to national language, back-translation to English,
verification of mismatch, again translation into national
language, translation by different persons). New meth-
ods based on innovative technological models could
provide a system to exchange information at lower costs
and with a wider spectrum of users. Only few articles
about dissemination information, of which none on the
MS disorder, have been written. Research on dissemina-
tion of information (how information about health care
interventions are created, packaged, transmitted, and
interpreted among a variety of important stakeholder
groups) is indicated in order to effectively facilitate
transfer of knowledge to evidence-based interventions.
Historical description of physical rehabilitation
In the last 60 years a great variety of techniques and
conceptual treatment methods have been proposed and
applied in the clinical field. Some methods have already
been used since the 1950 s (for example, the Bobath
concept, proprioceptive neuromuscular facilitation,
Vojta reflex locomotion) and are still in use [45]. Origin-
ally their theoretical approaches were based on the hier-
archic model of motor control and were applied in
physiotherapy as so called facilitation approaches. How-
ever, with the development of sophisticated imaging
methods like functional magnetic resonance imaging
and subsequently increasing knowledge on neuroplasti-
city and its prerequisites, the hierarchical model of
motor control has been contested. A more recent model
of motor control is the systems model [46] which forms
the basis for the task-oriented therapeutic approach, or
in a wider concept, problem solving approach, focusing
on specific disabilities of an individual patient. The
application of some “older” methods has changed in this
direction and new methods have been developed (for
example motor relearning programs).
All methods have in common that they apply internal
and external stimuli to achieve better movement, with
the aim of improving activities of daily living. The facili-
tation approach puts the accent on manual application
of stimuli (by proprioceptive and exteroceptive
stimulation, in Bobath concept e.g. by so called hand-
ling, in Vojta reflex locomotion by stimulating of so
called initiation zones in precisely-defined positions)
with the aim to facilitate and improve a given motor
function, movement pattern or to start a locomotion
program, while the quality of execution is carefully con-
trolled [47]. The task-oriented approach makes use of
mainly behavioral requests and a patient learns by
repeating a given specific task in different environ-
ments/under different conditions. The ability to carry
out a specific task may be more important than the
quality of the execution [48,49]. It can be argued that
task-oriented approach draws on or is close to the ICF
system [22,23,50] in that it considers recovery at the
activity level.
Theoretical bases of current clinical practice
Three main (physio-)therapeutic approaches based on
models of motor control are being used and discussed
nowadays [51]:
▪ muscle re-education, e.g. bio-feedback, aerobic
training, and muscle strengthening,
▪ neurotherapeutic facilitation, e.g. Vojta reflex
locomotion, Brunnström, Rood, Bobath, proprio-
ceptive neuromuscular facilitation, and the
▪ task-oriented approach, e.g. Petö concept,
Constraint-Induced Movement Therapy, Motor
Relearning Programme, “contemporary” (modi-
fied) Bobath concept, locomotor training and
Dual Tasking methods.
The theoretical bases of the different models are par-
tially overlapping and cannot in all cases be strictly
separated from each other. In the physiotherapeutic
practice it is usually very difficult to define the approach
used. Physiotherapists are led by their clinical experience
and intuition on the one hand and their knowledge of
evidence based medicine on the other. They sometimes
combine different therapeutic approaches based on dif-
ferent theoretical models, everybody with the same aim
to ameliorate functionality, participation and well-being
of PwMS. Nevertheless, it is obvious that the interven-
tions differ not only in content and terminology used,
but also in their definitions of content of treatment, par-
tial aims and understanding of therapeutic principles.
Conclusion
A Special Interest Group on Mobility, part of RIMS
http://www.rims.be aims at starting an inventory of con-
tent of physical rehabilitation both on the level of (i)
therapeutic content/philosophy/terminology and (ii) doc-
umentation of organisation of care (intensity and location
of treatment, clinicians involved in the process etc).
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actual MS rehabilitation practice across Europe but may
also serve as a basis for further (comparative) scientific
work to put MS- rehabilitation on a higher and more
widely applied level and so fulfil some of the demands
of the Code of Good Practice (to impact patients’ quality
of life, local and national health organizations, and
health insurance companies).
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